LONDON–(BUSINESS WIRE)–Tenpoint Therapeutics, Inc., a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye, today reported positive topline results from BRIO-II, the company’s second Phase …
Category: Business
FDA Clears Epithelial Thickness Module for Heidelberg Engineering’s ANTERION® Multidisciplinary Imaging Platform, Advancing Precision in Corneal Health Assessment
FRANKLIN, Mass.–(BUSINESS WIRE)–Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, is pleased to announce FDA clearance of the Epithelial Thickness Module, available exclusively through the ANTERION Cornea Ap…
Outcome Capital Congratulates Elios Vision on the Acquisition by Bausch + Lomb
BOSTON–(BUSINESS WIRE)–Outcome’s expertise in corporate strategy, financing, and transaction execution helped position ELIOS as a key innovator in glaucoma treatment market
EV Group successfully finalises an investment in Cornelius Group plc through a minority equity stake.
RHO, Italy–(BUSINESS WIRE)– #Chemicals–EV Group, a leading specialty chemicals and food ingredients distributor and manufacturer, and Cornelius Group (Cornelius), an international manufacturer and distributor of specialty additives and ingredients t…
Retinal Gene Therapy Market Report 2024-2034: Limited Treatment Reach and High Cost Likely to Hamper Industry Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Gene Therapy Market Report 2024-2034” report has been added to ResearchAndMarkets.com’s offering. Overall world revenue for the Retinal Gene Therapy Market will surpass US$110.0 million in 2024 This report will pro…
Ophthalmic Lasers Market Global Outlook & Forecast 2024-2029, with Key Vendor Profiles for Alcon, Bausch + Lomb, Johnson & Johnson, NIDEK and ZEISS – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Lasers Market – Global Outlook & Forecast 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The Ophthalmic Lasers Market was valued at USD 1.30 billion in 2023, and is projected to reach…
Canyon Labs Announces Strategic Acquisition of iuvo BioScience’s Lab Services and Consulting Businesses to Expand End-to-End Development Solutions
SALT LAKE CITY & ROCHESTER, N.Y.–(BUSINESS WIRE)–Canyon Labs, a global leader in analytical & packaging lab testing and consulting for medical devices and pharmaceuticals, and iuvo BioScience, a full service provider of ophthalmic medical device …
Lumentum Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index
SAN JOSE, Calif.–(BUSINESS WIRE)–Lumentum Holdings Inc. (“Lumentum”), a market-leading designer and manufacturer of innovative optical and photonic products for cloud, networking and industrial applications, announced today that it has received a per…
Cencora Completes Acquisition of Retina Consultants of America
CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading management services organization (MSO) of retina specialists. Cenco…
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Chief Financial Officer Sam …
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced the su…
Drug Farm Signs Agreement with National Institutes of Health (NIH) to Develop Precision Targeted Treatment for ROSAH Syndrome
GUILFORD, Conn. & ROCKVILLE, Md.–(BUSINESS WIRE)–Drug Farm, a clinical-stage biopharmaceutical company developing innovative treatments targeting innate immunity, announced today the signing of a Cooperative Research and Development Agreement (CRADA)…
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that its Reconvened Special Meeting of Stockholders held on December 18, 2024 has been adjourned until January 16, 2025 at 1…
GenSight Biologics fait un point sur les discussions réglementaires et sa situation financière
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” ou la “Société”) (Euronext : SIGHT, ISIN: FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniqu…
GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
Aurion Biotech Announces Positive Topline Data for Phase 1/2 Clinical Trial of AURN001, an Allogeneic Cell Therapy Product Candidate for the Treatment of Corneal Edema Secondary to Corneal Endothelial Dysfunction
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced topline data from its Phase 1/2 clinical t…
Local Organ, Eye and Tissue Donors, Living Donors and Recipients to be Honored on the 2025 OneLegacy Donate Life Rose Parade® Float on New Year’s Day
AZUSA, Calif.–(BUSINESS WIRE)–OneLegacy will honor 19 Southern Californians whose lives have been touched by the power of organ, eye and tissue donation on the 2025 OneLegacy Donate Life Rose Parade® float, themed “Let Your Life Soar.” The announceme…
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Limited (“Tenpoint”) and Visus Therapeutics, Inc., (“Visus”) announce today the completion of their merger to create an entirely new chapter in ophthalmic therapeutic medicines aimed at rejuvena…
Bausch + Lomb Responds to Rumors of a Potential Sale
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following statement in response to a request from the Canadian Investme…